HealthStream (HSTM) to Release Quarterly Earnings on Monday

HealthStream (NASDAQ:HSTM) is anticipated to issue its Q3 2025 results before the market opens on Monday, October 20th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $75.52 million for the quarter. HealthStream has set its FY 2025 guidance at EPS.Parties may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Tuesday, October 21, 2025 at 9:00 AM ET.

HealthStream (NASDAQ:HSTM) last announced its earnings results on Monday, August 4th. The technology company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.02. HealthStream had a net margin of 6.89% and a return on equity of 5.70%. The company had revenue of $74.40 million during the quarter, compared to analyst estimates of $74.39 million. On average, analysts expect HealthStream to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

HealthStream Trading Up 1.0%

HSTM opened at $26.54 on Friday. The stock has a 50-day moving average price of $27.68 and a 200-day moving average price of $28.35. HealthStream has a 12-month low of $25.00 and a 12-month high of $34.24. The stock has a market capitalization of $786.65 million, a P/E ratio of 39.61, a PEG ratio of 3.29 and a beta of 0.47.

HealthStream Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Monday, August 18th were paid a $0.031 dividend. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.12 annualized dividend and a yield of 0.5%. HealthStream’s dividend payout ratio is currently 17.91%.

Insider Buying and Selling at HealthStream

In other news, EVP Kevin P. O’hara sold 2,000 shares of the stock in a transaction that occurred on Wednesday, August 27th. The stock was sold at an average price of $27.97, for a total transaction of $55,940.00. Following the completion of the sale, the executive vice president owned 17,137 shares of the company’s stock, valued at approximately $479,321.89. This represents a 10.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 20.50% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Several institutional investors have recently added to or reduced their stakes in HSTM. JPMorgan Chase & Co. boosted its position in HealthStream by 302.0% during the 2nd quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company’s stock valued at $6,860,000 after buying an additional 186,231 shares during the period. Qube Research & Technologies Ltd boosted its holdings in shares of HealthStream by 77.3% during the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company’s stock worth $6,972,000 after purchasing an additional 109,883 shares during the period. Bank of America Corp DE boosted its holdings in shares of HealthStream by 56.2% during the second quarter. Bank of America Corp DE now owns 141,282 shares of the technology company’s stock worth $3,909,000 after purchasing an additional 50,852 shares during the period. Jane Street Group LLC purchased a new stake in shares of HealthStream during the first quarter worth about $1,532,000. Finally, Royal Bank of Canada lifted its holdings in HealthStream by 194.2% in the 1st quarter. Royal Bank of Canada now owns 43,899 shares of the technology company’s stock worth $1,413,000 after buying an additional 28,977 shares during the period. Hedge funds and other institutional investors own 69.58% of the company’s stock.

Analysts Set New Price Targets

HSTM has been the subject of several research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of HealthStream in a research note on Wednesday, October 8th. Canaccord Genuity Group cut their price objective on shares of HealthStream from $29.00 to $28.00 and set a “hold” rating for the company in a research note on Thursday, August 7th. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, HealthStream has an average rating of “Hold” and a consensus target price of $31.00.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.